| MolName | 6-[(5Z)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid |
| MolecularFormula | C26H26N4O5S2 |
| Smiles | OC(CNC(N=C1N2C=CC=C1)=C(/C=C(/C(N1CCCCCC(O)=O)=O)\SC1=S)C2=O)c1ccccc1 |
| InChI | InChI=1S/C26H26N4O5S2/c31-19(17-9-3-1-4-10-17)16-27-23-18(24(34)29-13-8-6-11-21(29)28-23)15-20-25(35)30(26(36)37-20)14-7-2-5-12-22(32)33/h1,3-4,6,8-11,13,15,19,27,31H,2,5,7,12,14,16H2,(H,32,33)/t19-/m0/s1 |
| InChIK | YYIFXLNGROFZMR-IBGZPJMESA-N |
| TotalMolweight | 538.647 |
| Molweight | 538.647 |
| MonoisotopicMass | 538.134461 |
| CLogP | 0.9315 |
| CLogS | -5.194 |
| H Acceptors | 9 |
| H Donors | 3 |
| TotalSurfaceArea | 399.63 |
| Relative PSA | 0.35253 |
| PolarSurfaceArea | 179.93 |
| Druglikeness | -2.736 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.54054 |
| Fragments | 1 |
| Non HAtoms | 37 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 11 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 11 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| AcidicOxygens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - 6-[(5Z)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid | 2 - 6-[(5Z)-5-[[2-[(2-hydroxy-2-phenylethyl)amino]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoic acid